Spotlight Presentation: Engineering Unique Properties in Next-Gen Antibody Therapies
25 Sep 2025
Immunogenicity
Immune Regulation
Translational Immunology
Immune Biomarkers
Clinical Development
)
We will explore some of the cutting-edge advancements in our antibody discovery and engineering approaches to engineer unique properties in next generation therapeutic antibodies, including an introduction to AvantGen’s AIMED™ Platform. With the aim to enhance specificity, potency, and to expand the therapeutic index, we will discuss how they hold the promise to significantly improve patient outcomes.
Industry Expert
